| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |